Frances Grimstad

ORCID: 0000-0002-2442-724X · 13 papers in corpus
article 2025
·doi:10.1097/ogx.0000000000001408

(Abstracted from J Pediatr Adolesc Gynecol 2024;37(4):402–406 One of the leading causes of dysmenorrhea in adolescents is endometriosis, or the growth of endometrial tissue outside the uterus. Endometriosis significantly impacts quality of …

other 2024
Women's health (London, England) ·doi:10.1177/17455057241265081

BACKGROUND: Danazol is a synthetic progestin with androgenic effects that is approved by the Food and Drug Administration for treatment of endometriosis, benign fibrocystic breast disease, and hereditary angioedema. In recent years, increas…

article 2024
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2024.02.003

STUDY OBJECTIVE: To evaluate the efficacy and tolerability of a progestin-only pill containing 4 mg drospirenone (DRSP) as a hormonal therapy for the management of endometriosis-associated symptoms in adolescents and young adults. DESIGN: …

other 2023
The journal of sexual medicine ·doi:10.1093/jsxmed/qdad135

BACKGROUND: Pelvic pain has been reported in transmasculine individuals taking testosterone. There is a need for further investigation to increase understanding of the prevalence and risk factors of this pain. AIM: We sought to determine t…

article 2022
·doi:10.1016/j.jadohealth.2022.01.036
article 2022
The journal of sexual medicine ·doi:10.1016/j.jsxm.2022.03.606

BACKGROUND: Sexual minority (lesbian, bisexual, mostly heterosexual) young women face many sexual and reproductive health disparities, but there is scant information on their experiences of chronic pelvic pain, including an absence of infor…

other 2021
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2021.04.004

STUDY OBJECTIVE: Amenorrhea is a goal of many transgender and gender diverse adolescent and young adult (TGD AYA) patients on testosterone gender-affirming hormone therapy (T-GAHT). Breakthrough bleeding can contribute to worsening gender d…

article 2021
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2021.09.010

Study objectiveTo study the feasibility of virtual visits for ambulatory encounters in pediatric and adolescent gynecology DESIGN: A retrospective review SETTING: Boston Children's Hospital PARTICIPANTS: Patients who were seen virtually thr…

article 2020
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2020.06.001

Study objectiveTo study the presentation of dysmenorrhea and endometriosis in transmasculine adolescents and review their treatment outcomes.DesignA retrospective review.SettingBoston Children's Hospital.ParticipantsTransmasculine persons y…

article 2019
·doi:10.1016/j.jpag.2019.02.088
article 2018
·doi:10.1016/j.jpag.2018.02.080
review 2017
Clinical obstetrics and gynecology ·doi:10.1097/grf.0000000000000298

Epigenetic influences have been postulated to affect the course of endometriosis. DNA methyltransferases, estrogen and progesterone receptors, micro-RNAs, and histone deacetylators, have shown differential expression in endometriosis compar…

review 2015
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2015.02.002

Endometriosis affects 6% to 10% of women of reproductive age; extrapelvic endometriosis is considered a rare event with perineal endometriosis being even rarer still (only a few cases of spontaneous episodes described, the majority being fr…